Lanxess (ETR:LXS) has been assigned a €64.00 ($74.42) price target by analysts at Morgan Stanley in a research note issued to investors on Friday. The firm currently has a “neutral” rating on the stock. Morgan Stanley’s price objective suggests a potential upside of 9.93% from the company’s current price.

Several other analysts have also recently issued reports on the company. UBS Group set a €78.00 ($90.70) target price on Lanxess and gave the company a “buy” rating in a research report on Wednesday. Goldman Sachs Group set a €84.00 ($97.67) target price on Lanxess and gave the company a “buy” rating in a research report on Monday, October 8th. Credit Suisse Group set a €70.00 ($81.40) price objective on Lanxess and gave the stock a “neutral” rating in a research report on Wednesday, October 3rd. BNP Paribas set a €74.00 ($86.05) price objective on Lanxess and gave the stock a “neutral” rating in a research report on Tuesday, October 2nd. Finally, Deutsche Bank set a €68.00 ($79.07) price objective on Lanxess and gave the stock a “neutral” rating in a research report on Monday, October 1st. Three equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and ten have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of €73.73 ($85.73).

Shares of ETR LXS opened at €58.22 ($67.70) on Friday. Lanxess has a 12-month low of €59.89 ($69.64) and a 12-month high of €74.50 ($86.63).

About Lanxess

LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.

See Also: Stock Selection – What is cash flow?

Analyst Recommendations for Lanxess (ETR:LXS)

Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.